Amgen Shareholders May Question Executive Compensation at Annual Meeting

http://www.vcstar.com/news/2011/may/17/amgen-shareholders-may-question-executive-at/

"Institutional Shareholder Services calculated his stock options to be valued at nearly $9.8 million, compared with Amgen's $6.7 million valuation."

It's media quotes like this that draw folks to read these articles.  If this article dived into the different valuation methods and why, the reader reaction, I'm sure, would be very different.  Either way, ISS has it's opinions and might to push its views.  Interesting read.